Associated Papers
Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733.
Crawford ED et al.
Plos One, 2017
28542423 (PubMed )
Supplement: pone.0178163.s003.xlsx › ACP-B6-P412T_vs_ACP-B6
Select a paper to view details